UnknownNot Applicable

Pulmonary Fibrosis Lung Sounds Study

100 participantsStarted 2023-03

Plain-language summary

The goal of this observational study is to test whether it is possible to detect particular lung sounds that are unique to patients with the lung disease pulmonary fibrosis and whether any such sounds could be analysed using machine learning to make diagnosing disease easier. Participants will have a sound detection device placed in different locations on the chest and audio sounds will be recorded for analysis. Researchers will compare audio recordings from clinically diagnosed patients with recordings from healthy controls of a similar age to see whether the sounds are sufficiently different within that age group.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria * Able to understand what the study involves * Able and willing to give informed consent For patients: * Age≥60 (PF affects adults, with the majority of age≥60) * A diagnosis of progressive pulmonary fibrosis (to include all diagnosed interstitial lung disease (ILD) patients presenting at the ILD clinic) For healthy controls: * Age≥60 (to ensure that age of controls is similar to that of patients so that younger age does not bias results) * No known lung disease Exclusion Criteria * Unable to understand what the study involves * Unwilling or unable to give consent * Age\<60 (to ensure that age does not confound results and cases and controls are of similar age, since the majority of pulmonary fibrosis patients are of age≥60)

What they're measuring

Number of clinical lung sound recordings stored from pulmonary fibrosis cases and controls

Timeframe: 6 months

Measure of ability of this system to classify participants as PF patients or healthy controls

Timeframe: 8 months

Feedback from patients and study clinicians

Timeframe: 8 months

Trial details

NCT IDNCT05771740

SponsorRoyal Devon and Exeter NHS Foundation Trust

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-12

Contact for this trial

Anna Duckworth, PhD

07785386194 ad653@exeter.ac.uk

View on ClinicalTrials.gov More Pulmonary Fibrosis trials

Plain-language summary

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.